FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,985 | -90.6% | 417 | -88.7% | 0.00% | -100.0% |
| Q1 2023 | $21,062 | +182.4% | 3,695 | +400.0% | 0.00% | +100.0% |
| Q4 2022 | $7,457 | – | 739 | +4247.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 17 | -50.0% | 0.00% | – |
| Q2 2022 | $1,000 | -88.9% | 34 | -85.2% | 0.00% | -100.0% |
| Q1 2022 | $9,000 | +350.0% | 230 | +475.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 40 | +471.4% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 7 | +16.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 6 | -25.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |